Estimating progression-free survival in patients with glioblastoma using routinely collected data

Glioblastoma (GBM) represents 80% of all primary malignant brain tumours in adults. Prognosis is poor, and there is a clear correlation between disease progression and deterioration in functional status. In this pilot study we assess whether we can estimate disease progression and progression free s...

Descripción completa

Detalles Bibliográficos
Autores principales: Kelly, Charlotte, Majewska, Paulina, Ioannidis, Stefanos, Raza, Muhammad Hasan, Williams, Matt
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2017
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5700233/
https://www.ncbi.nlm.nih.gov/pubmed/28956223
http://dx.doi.org/10.1007/s11060-017-2619-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5700233/
https://www.ncbi.nlm.nih.gov/pubmed/28956223
http://dx.doi.org/10.1007/s11060-017-2619-1

Ejemplares similares